Regenerative Medicine Research Program, US Army Institute of Surgical Research, Fort Sam, Houston, Texas, USA.
Tissue Eng Part A. 2011 Apr;17(7-8):941-53. doi: 10.1089/ten.TEA.2010.0294. Epub 2011 Jan 4.
This work describes the differentiation of adipose-derived mesenchymal stem cells (ASC) in a composite hydrogel for use as a vascularized dermal matrix. Our intent is that such a construct could be utilized following large-surface-area burn wounds that require extensive skin grafting and that are limited by the availability of uninjured sites. To develop engineered skin replacement constructs, we are pursuing the use of ASC. We have established that a PEGylated fibrin gel can provide a suitable environment for the proliferation of ASC over a 7 day time course. Further, we have demonstrated that PEGylated fibrin can be used to control ASC differentiation toward vascular cell types, including cells characteristic of both endothelial cells and pericytes. Gene expression analysis revealed strong upregulation of endothelial markers, CD31, and von Willebrand factor, up to day 11 in culture with corresponding evidence of protein expression demonstrated by immunocytochemical staining. ASC were not only shown to express endothelial cell phenotype, but a subset of the ASC expressed pericyte markers. The NG2 gene was upregulated over 11 days with corresponding evidence for the cell surface marker. Platelet-derived growth factor receptor beta gene expression decreased as the multipotent ASC differentiated up to day 7. Increased receptor expression at day 11 was likely due to the enhanced pericyte gene expression profile, including increased NG2 expression. We have also demonstrated that when cells are loaded onto chitosan microspheres and sandwiched between the PEGylated fibrin gel and a type I collagen gel, the cells can migrate and proliferate within the two different gel types. The matrix composition dictates the lineage specification and is not driven by soluble factors. Utilizing an insoluble bilayer matrix to direct ASC differentiation will allow for the development of both vasculature as well as dermal connective tissue from a single population of ASC. This work underscores the importance of the extracellular matrix in controlling stem cell phenotype. It is our goal to develop layered composites as wound dressings or vascularized dermal equivalents that are not limited by nutrient diffusion.
这项工作描述了脂肪间充质干细胞(ASC)在复合水凝胶中的分化,用于作为血管化真皮基质。我们的意图是,在需要广泛植皮且因未受伤部位有限而受到限制的大面积烧伤创面后,可以使用这种构建体。为了开发工程化皮肤替代物构建体,我们正在研究使用 ASC。我们已经确定,聚乙二醇化纤维蛋白凝胶可以为 ASC 的增殖提供合适的环境,时间长达 7 天。此外,我们已经证明,聚乙二醇化纤维蛋白可用于控制 ASC 向血管细胞类型分化,包括内皮细胞和周细胞的特征细胞。基因表达分析显示,内皮标记物 CD31 和血管性血友病因子的表达在培养第 11 天之前强烈上调,免疫细胞化学染色显示相应的蛋白表达证据。ASC 不仅表现出内皮细胞表型,而且亚群 ASC 还表达周细胞标记物。NG2 基因在 11 天内上调,细胞表面标记物也有相应证据。血小板衍生生长因子受体β基因表达在多能 ASC 分化至第 7 天之前下降。第 11 天受体表达增加可能是由于周细胞基因表达谱增强,包括 NG2 表达增加。我们还证明,当细胞加载到壳聚糖微球上并夹在聚乙二醇化纤维蛋白凝胶和 I 型胶原凝胶之间时,细胞可以在两种不同的凝胶类型中迁移和增殖。基质组成决定谱系特异性,而不是由可溶性因子驱动。利用不可溶性双层基质来指导 ASC 分化将允许从单个 ASC 群体中同时发育血管和真皮结缔组织。这项工作强调了细胞外基质在控制干细胞表型方面的重要性。我们的目标是开发分层复合材料,作为伤口敷料或血管化真皮等效物,不受营养扩散的限制。